PRESS-RELEASE ·Filed May 14, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the Q1 2026 earnings release on May 18 for clinical pipeline updates and cash runway. No immediate trading catalyst from this notice.
Final — all horizons settled through T+60d
NRXP ▲ +4.36% at T+60d
NEUTRAL call ✓ call won +4.36% · α vs SPY +0.77% · entry $3.21 → $3.35
T+1d
+2.18%
call +2.18% · α +3.41%
$3.28
settled 5mo ago
T+5d
-4.67%
call -4.67% · α -3.96%
$3.06
settled 4mo ago
T+20d
+19.63%
call +19.63% · α +20.48%
$3.84
settled 4mo ago
T+60d
+4.36%
call +4.36% · α +0.77%
$3.35
settled 7w ago
Price Chart
Loading chart...
Executive Summary
NRx Pharmaceuticals announced it will release Q1 2026 financial results before market open on May 18, 2026, followed by a conference call. No financial data or guidance was provided in this press release.
Key Facts
- Q1 2026 earnings release scheduled for May 18, 2026 before market open
- Conference call at 8:00am ET on May 18, 2026
- No preliminary financial results or guidance disclosed
Financial Impact
Not specified
Risk Factors
- Clinical-stage company with no approved products; high cash burn risk
- Uncertainty around regulatory path for NRX-100 and NRX-101
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3294715 |
16 reports for NRXP
82% Hit rate best @ T+60▲ +70.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $3.35 $3.16 | ▼ −5.67% | ▼ −8.24% | $2.90 (−13.28%) |
Sep 14, 2026 18d ago | 8-K | $3.49 $3.29 | ▼ −5.73% | ▼ −5.84% | $2.90 (−16.76%) |
Aug 17, 2026 6w ago | 8-K | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 17, 2026 6w ago | Press Release | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 7, 2026 8w ago | 8-K | $3.58 $3.27 | ▼ −8.66% | ▼ −9.06% | $2.90 (−18.85%) |
Jul 22, 2026 10w ago | 8-K | $4.48 $3.23 | ▼ −27.90% | ▼ −25.50% | $2.90 (−35.16%) |
Jun 22, 2026 14w ago | Press Release | $3.90 $3.73 | ▼ −4.36% | ▼ −2.29% | $2.90 (−25.51%) |
Jun 5, 2026 17w ago | Press Release | $4.14 $3.84 | ▼ −7.25% | ▼ −7.82% | $2.90 (−29.83%) |
Jun 4, 2026 17w ago | Press Release | $4.14 $3.84 | ▲ +7.25% | ▲ +7.82% | $2.90 (+29.83%) |
Jun 3, 2026 17w ago | Press Release | $4.05 $3.76 | ▲ +7.16% | ▲ +3.34% | $2.90 (+28.27%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Mon (64h 7m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access